Friday 6 November 2026 Export PEN’s income statement to Excel — free account

Penumbra, Inc.

PEN Healthcare Medical Devices

Penumbra, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.5% from fiscal 2024.

Revenue: +15.6%
EPS: −8.29%
Free cash flow: −37.2%
Total debt: −10.3%

Quarter to September 2026, against a year earlier

320.08 1.03 −0.32%

Follow PEN

Alert me

Market cap: $12.7B
P/E: 80.3×
Fwd P/E: 68.7×
Dividend yield: —
F-score: 8/9
Altman Z: 20.17
Beneish M: −2.48
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Penumbra, Inc. (PEN) Debt to equity

Alert me on Debt to equity

Penumbra, Inc.'s debt to equity at the end of the quarter to 30 September 2026 was 0.0×, down 0.0× from fiscal 2025 (0.0×). Over the past ten years it has ranged from 0.0× (fiscal 2018) to 0.1× (fiscal 2019); the current reading is higher than 45% of that period. That is below the Medical Devices industry median of 0.0× and above the Healthcare sector median of 0.0×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/PEN/debt-to-equity" width="100%" height="360" style="border:0" loading="lazy" title="Penumbra, Inc. debt to equity, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/PEN/metrics/debt-to-equity">Penumbra, Inc. (PEN) debt to equity — stockrow.com</a></p>

Period	Debt to equity	Change
FY2025	0.0×	(23.28%)
FY2024	0.0×	(5.97%)
FY2023	0.0×	(19.28%)
FY2022	0.0×	(10.43%)
FY2021	0.0×	(34.43%)
FY2020	0.0×	(23.05%)
FY2019	0.1×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	Debt to equity	Change
Sep 2026	0.0×	(6.25%)
Jun 2026	0.0×	(6.57%)
Mar 2026	0.0×	(5.52%)
Dec 2025	0.0×	(7.05%)
43 more quarters	Free account

Against its own ten years

Low 0.0× High 0.1×

Ten-year median 0.0×

Current reading's percentile 45

Company	Debt to equity
GMED Globus Medical, Inc. compare	0.0×
TXG 10x Genomics compare	0.0×
PEN Penumbra, Inc.	0.0×
GKOS Glaukos Corporation compare	0.1×
BIO Bio-Rad Laboratories, Inc. compare	0.2×
BIO.B Bio-Rad Laboratories, Inc. compare	0.2×
PODD Insulet Corporation compare	0.6×
SNN Smith & Nephew SNATS, Inc. compare	0.6×
BRKR Bruker Corporation compare	0.7×
Medical Devices industry median	0.0×
Healthcare sector median	0.0×
Market median	0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

Penumbra, Inc. (PEN) Debt to equity

Debt to equity, annual

Annual newest first

Quarterly newest first

Against its own ten years

Debt to equity against peers

What Debt to equity is

More on PEN

Debt to equity, annual

Annual newest first

Quarterly newest first

Against its own ten years

Debt to equity against peers

What Debt to equity is

More on PEN

Stockrow Weekly